EquiVision® (exclusive for equine
use) has been developed and formulated to treat incipient cataracts,
immature cataracts (when a tapetal reflection is still visible),
nuclear sclerosis, and dry eye syndrome (KCS).
EquiVision® is sold only through
If you have any questions about the use of our products, please refer
to the Frequently Asked Questions (FAQs) section
or contact us at firstname.lastname@example.org.
New prophylactic solution to reduce the risk of
the development of cataracts in young equine.
For Sales, contact us at email@example.com
Our recommendation: Do not
use any ophthalmic steroid or steroid derivative in combination
these products cancel the positive effects of our eye drops,
although they carry no risk for your equine.